AKT3 and breast cancer: To sum up, it was found in the present study that miR-16-5p exhibited a low expression in breast cancer tissues, and the highly expressed miR-16-5p may impede the occurrence of breast cancer via modulating AKT3 and hindering the NF-κB pathway.